Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder Cancer

Clinical trial NCT02718742 · WITHDRAWN

Trial details

NCT number: NCT02718742
Sponsor: Mayo Clinic
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Bladder Urothelial Carcinoma Stage IV Bladder Urothelial Carcinoma

Start date: 2016-06-01
Primary completion: 2021-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.